Skip to main content

Closed

NMRA: Neumora Therapeutics, Inc. Common Stock Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-179.8%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage-48.1×

Current ratio5.09×

Neumora Therapeutics, Inc. Common Stock

NMRANASDAQ Global Select·USD·Closed

Neumora Therapeutics, Inc. Common Stock

NMRANASDAQ·USD·Closed

$1.61

−2.42%

$1.61

−$0.04 (2.42%)

52W Range

28thpctl

Volume

0.76×avg

Mkt Cap

298.31MUSD

P/E

-1.2TTM

Div Yield

–ann

52W Range

28thpctl

Volume

0.76×avg

Market Cap

298.31MUSD

P/E Ratio

-1.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings